Diagnosis And Risk Stratification Of Fungal Infections

Abstract

The invention relates to a method for the diagnosis and/or risk stratification of invasive fungal infections (IFI) / invasive fungal diseases (IFD) and in particular associated with sepsis or septic shock, wherein a determination of the marker proadrenomedullin (proADM) or a partial peptide or fragment thereof, in particular midregional proadrenomedullin (MR-proADM), or contained in a marker combination (panel, cluster), is carried out from a patient to be examined. Furthermore, the invention relates to a diagnostic assay and a kit for carrying out the method.


Claims
Download PDF
Document Preview
Document History
  • Publication: Feb 7, 2019
  • Application: Aug 6, 2018
    WO EP 2018071305 W
  • Priority: Aug 4, 2017
    EP EP 17185036 A

Download Citation


Sign in to the Lens

Feedback